Exagen Diagnostics: Debra Jeske, Anja Kammesheidt

Exagen Diagnostics has appointed Debra Jeske as its chief medical officer and Anja Kammesheidt as its chief scientific officer. Zack is a board-certified rheumatologist and was previously vice president of clinical development at Xencor. Before that, she was executive director and medical scientific leader for the biotherapeutics development unit at Novartis. She also has held a number of positions in basic research, clinical development, and medical affairs at Amgen.

Kammesheidt was CSO at Ambry Genetics and at Pathway Genoics. She also has held R&D positions at Agendia and Purdue Pharma. She replaces Thierry Dervieux, who has been a consultant to Exagen since he resigned from the company in Q4 2019 to pursue other opportunities.